TRANSFORMATION OF CANNABINOL AND TERPENE OILS INTO WATER SOLUBLE DRY POWDERS FOR SOLID FORM SUBLINGUAL DELIVERY
A composition includes a clathrate compound that has guest molecules and carrier molecules that trap the guest molecules. The carrier molecules are a saccharide and the guest molecules include at least one of a cannabinoid or a terpene. The clathrate compound includes, by combined weight of the carrier molecules and the guest molecules, at least 18% of the guest molecules.
1 . A composition comprising:
a clathrate compound including guest molecules and carrier molecules trapping the guest molecules, wherein the carrier molecules are a saccharide and the guest molecules include at least one of a cannabinoid or a terpene, the clathrate compound including, by combined weight of the carrier molecules and the guest molecules, at least 18% of the guest molecules.
2 . The composition as recited in claim 1 , wherein the saccharide is cyclic.
3 . The composition as recited in claim 1 , wherein the saccharide is linear.
4 . The composition as recited in claim 1 , wherein the carrier molecules include beta cyclodextrin.
5 . The composition as recited in claim 1 , wherein the carrier molecules include 2-hydroxypropyl-beta-cyclodextrin.
6 . The composition as recited in claim 1 , wherein the guest molecules include the terpene.
7 . The composition as recited in claim 1 , wherein the guest molecules include the cannabinoid.
8 . The composition as recited in claim 1 , wherein the carrier molecules include beta cyclodextrin and the guest molecules include the cannabinoid.
9 . The composition as recited in claim 8 , wherein cannabinoid is selected from the group consisting of tetrahydrocannabinol, cannabidiol, cannabinol, cannabavarin, cannabigerol, cannabichromene, delta- 8 -THC, cannabicyclol, cannabitriol, cannabielsoin, and combinations thereof.
10 . The composition as recited in claim 1 , wherein the clathrate compound includes, by combined weight of the carrier molecules and the guest molecules, up to 40% of the guest molecules.
11 . A method of fabricating a clathrate compound, the method comprising:
providing a liquid solution of a first solvent and a second, different solvent;
providing carrier molecules which are soluble in the first solvent and guest molecules which are soluble in the second solvent and insoluble in the first solvent, wherein the carrier molecules are a saccharide and the guest molecules include at least one of a cannabinoid or a terpene;
dissolving in the liquid solution a first amount of the carrier molecules and a second amount of the guest molecules that is at least 1 molar equivalent to the first amount; and
decreasing a concentration of the second solvent in the liquid solution to cause the guest molecules to form a clathrate compound with the carrier molecules in which the carrier molecules trap the guest molecules.
12 . The method as recited in claim 11 , further comprising, after the decreasing of the concentration, evaporating the liquid solution to produce a dry clathrate compound.
13 . The method as recited in claim 11 , wherein the second solvent is alcohol.
14 . The method as recited in claim 13 , wherein the first solvent is water.
15 . The method as recited in claim 14 , wherein the liquid solution contains, by volume, at least 90% of propanol.
16 . The method as recited in claim 15 , wherein the carrier molecules include beta cyclodextrin.
17 . The method as recited in claim 11 , wherein the decreasing of the concentration involves heating the liquid solution to a temperature above the boiling point of the second solvent.
18 . A tablet comprising:
one or more excipients; and
a powder containing a clathrate compound including guest molecules and carrier molecules trapping the guest molecules, wherein the carrier molecules are a saccharide and the guest molecules include at least one of a cannabinoid or a terpene, the clathrate compound including, by combined weight of the carrier molecules and the guest molecules, at least 18% of the guest molecules.
19 . The tablet as recited in claim 18 , wherein the carrier molecules include beta cyclodextrin and the guest molecules include the cannabinoid.
20 . The tablet as recited in claim 19 , wherein cannabinoid is selected from the group consisting of tetrahydrocannabinol, cannabidiol, cannabinol, cannabavarin, cannabigerol, cannabichromene, delta-8-THC, cannabicyclol, cannabitriol, cannabielsoin, and combinations thereof.